← Insiders

BBD

Bullish signal

Factor checklist — research, not advice

A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.

ACHAT TOTAL: 468674 titres (~8426759 USD) VENTE TOTALE: 120089 titres (~2215250 USD)

Insiders
de Oliveira Andre Luis Duartede Souza Cintia Scovine BarcelosFernandes Oswaldo TadeuPanico AlexandreParis Roberto de JesusPedras Carlos Henrique VillelaRamalho Miranda Jose AugustoScarpelli Cassiano Ricardo
Total bought
$8,426,759

Avg buy (VWAP, 90d window) $17.98 vs last close $3.41 (-81.0%)

Total sold
$2,215,250

Avg sell (VWAP, 90d window) $18.44 vs last close $3.41 (-81.5%)

Last activity
2026-09-18
Liquidity
Liquid $95,229,601/day · 20d vol
Last synced
2026-09-25 21:10:10 Synced via automated research pipeline

Sign in to request a sync of this company's price history and timing levels.

Insider holdings as a share of total assets aren't available for this company.

Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.

Recent Form 4

Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.

Date Person Side Shares Price Value Form 4
2026-09-18 Alvarez Denise Aguiar Buy 130,596 $17.98 $2,348,116 Form 4
2026-09-18 Alvarez Rubens Aguiar Buy 46,874 $17.98 $842,795 Form 4
2026-09-18 Bueno Julio Cesar Buy 56,355 $17.98 $1,013,263 Form 4
2026-09-18 Caffarelli Paulo Rogerio Buy 31,266 $17.98 $562,163 Form 4
2026-09-18 Favarao Vinicius Urias Buy 60,492 $17.98 $1,087,646 Form 4
2026-09-18 Fernandes Oswaldo Tadeu Buy 79,782 $17.98 $1,434,480 Form 4
2026-09-18 Freiberger Fernando Buy 49,550 $17.98 $890,909 Form 4
2026-09-18 Machado Silvana Rosa Buy 62,048 $17.98 $1,115,623 Form 4
2026-09-18 Mantarro Renata Geiser Buy 54,760 $17.98 $984,585 Form 4
2026-09-18 Marcilio Juliano Ribeiro Buy 60,779 $17.98 $1,092,806 Form 4
2026-09-18 Nunes Regina Helena Jorge Buy 31,266 $17.98 $562,163 Form 4
2026-09-18 Paris Roberto de Jesus Buy 96,702 $17.98 $1,738,702 Form 4
2026-09-18 Pavarina Denise Pauli Buy 46,874 $17.98 $842,795 Form 4
2026-09-18 Ramalho Miranda Jose Augusto Buy 63,719 $17.98 $1,145,668 Form 4
2026-09-18 Tescarolo Marcos Valerio Buy 57,012 $17.98 $1,025,076 Form 4
2026-09-18 de Oliveira Tulio Xavier Buy 55,444 $17.98 $996,883 Form 4
2026-09-18 Panico Alexandre Buy 43,620 $17.98 $784,288 Form 4
2026-09-18 Pedras Carlos Henrique Villela Buy 55,850 $17.98 $1,004,183 Form 4
2026-09-18 da Cunha Paulo Roberto Simoes Buy 46,874 $17.98 $842,795 Form 4
2026-09-18 de Oliveira Andre Luis Duarte Buy 309,111 $17.98 $5,557,816 Form 4
2026-09-18 de Souza Cintia Scovine Barcelos Buy 60,093 $17.98 $1,080,472 Form 4
2026-09-10 Paris Roberto de Jesus Sell 25,000 $18.50 $462,500 Form 4
2026-09-10 Scarpelli Cassiano Ricardo Sell 70,000 $18.50 $1,295,000 Form 4
2026-09-08 Fernandes Oswaldo Tadeu Sell 12 $18.41 $221 Form 4
2026-09-08 Paris Roberto de Jesus Sell 25,000 $18.25 $456,250 Form 4
2026-08-25 Ramalho Miranda Jose Augusto Sell 77 $16.61 $1,279 Form 4
2026-08-13 Ramalho Miranda Jose Augusto Sell 60 $0.06 $4 Form 4
2026-07-01 Bueno Julio Cesar Buy 41 $18.11 $743 Form 4

Price (1 year)

Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.

Market snapshot

Signal

Bullish signalScored 2026-09-22

Despite a meaningful insider cluster buy signal (score 75, confidence 0.7) and a modest YoY net income improvement, BBD's underlying financial health is critically impaired, with a liquidity score of 20 and a…

The first sentence of the analysis written for BBD on 2026-09-22 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.

Financial ratios

MetricTrend2025-12-312024-12-312023-12-312022-12-312021-12-31
Gross Profit Margin28.6%31.5%26.8%34.4%59.1%
Ebit Margin6.7%6.8%4.0%10.3%20.9%
Ebitda Margin9.0%9.5%6.6%12.6%24.5%
Operating Profit Margin6.7%6.8%4.0%10.3%20.9%
Pretax Profit Margin6.7%6.8%4.0%10.3%20.9%
Continuous Operations Profit Margin7.7%7.0%5.7%9.0%14.8%
Net Profit Margin7.6%6.9%5.6%8.9%14.7%
Bottom Line Profit Margin7.6%3.3%2.7%4.2%14.7%
Current Ratio0.5790.5470.6090.4830.482
Quick Ratio0.5790.5470.6090.4830.482
Solvency Ratio0.0140.0130.0120.0160.019
Cash Ratio0.3420.1790.1900.1740.148
Price To Earnings Ratio8.1427.26313.0688.0528.367
Price To Earnings Growth Ratio0.2180.256-0.398-0.9260.179
Forward Price To Earnings Growth Ratio0.2180.256-0.398-0.9260.179
Price To Earnings Diluted Ratio8.1427.26313.0688.0528.367
Price To Earnings Diluted Growth Ratio0.2180.256-0.398-0.9260.179
Price To Book Ratio1.0810.7461.0621.0171.357
Price To Sales Ratio0.6190.5030.6930.6771.290
Price To Free Cash Flow Ratio0.748-1.342-18.9544.019-1.911
Price To Operating Cash Flow Ratio0.733-1.376-994.3053.259-1.993
Debt To Assets Ratio0.3410.3330.3280.3190.143
Debt To Equity Ratio4.4494.0943.7993.5851.595
Debt To Capital Ratio0.8160.8040.7920.7820.615
Long Term Debt To Capital Ratio0.6610.7050.6810.6840.610
Financial Leverage Ratio13.06112.28811.58811.23411.187
Working Capital Turnover Ratio-1.021-0.641-0.655-0.549-0.413
Operating Cash Flow Ratio0.597-0.097-0.0000.061-0.118
Operating Cash Flow Sales Ratio0.844-0.366-0.0010.208-0.647
Free Cash Flow Operating Cash Flow Ratio0.9811.02552.4590.8111.043
Debt Service Coverage Ratio0.0490.0570.0490.0770.529
Interest Coverage Ratio0.1080.1170.0650.1880.596
Short Term Operating Cash Flow Coverage Ratio0.597-0.323-0.0010.2230.000
Operating Cash Flow Coverage Ratio0.331-0.132-0.0000.087-0.427
Capital Expenditure Coverage Ratio52.377-39.775-0.0195.288-23.128
Dividend Paid And Capex Coverage Ratio15.605-10.333-0.0073.542-7.120
Dividend Payout Ratio0.5000.3791.1920.2190.428
Enterprise Value Multiple29.77227.36838.05919.5198.125

Sparkline shows each ratio oldest → newest (left → right).

How the latest year compares

For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower

MetricCurrentvs 1Y agovs 5Y avg
Gross Profit Margin 28.6% ▼-2.9% ▼-7.5%
Ebit Margin 6.8% ▼-0.0% ▼-3.0%
Ebitda Margin 9.0% ▼-0.5% ▼-3.4%
Operating Profit Margin 6.8% ▼-0.0% ▼-3.0%
Pretax Profit Margin 6.8% ▼-0.0% ▼-3.0%
Continuous Operations Profit Margin 7.7% ▲0.7% ▼-1.2%
Net Profit Margin 7.6% ▲0.7% ▼-1.1%
Bottom Line Profit Margin 7.6% ▲4.3% ▲1.1%
Current Ratio 0.579 ▲0.032 ▲0.039
Quick Ratio 0.579 ▲0.032 ▲0.039
Solvency Ratio 0.014 ▲0.002 ▼-0.001
Cash Ratio 0.342 ▲0.162 ▲0.135
Price To Earnings Ratio 8.142 ▲0.879 ▼-0.836
Price To Earnings Growth Ratio 0.218 ▼-0.039 ▲0.352
Forward Price To Earnings Growth Ratio 0.218 ▼-0.039 ▲0.352
Price To Earnings Diluted Ratio 8.142 ▲0.879 ▼-0.836
Price To Earnings Diluted Growth Ratio 0.218 ▼-0.039 ▲0.352
Price To Book Ratio 1.081 ▲0.335 ▲0.029
Price To Sales Ratio 0.619 ▲0.116 ▼-0.138
Price To Free Cash Flow Ratio 0.748 ▲2.090 ▲4.236
Price To Operating Cash Flow Ratio 0.734 ▲2.110 ▲199.470
Debt To Assets Ratio 0.341 ▲0.007 ▲0.048
Debt To Equity Ratio 4.449 ▲0.355 ▲0.945
Debt To Capital Ratio 0.817 ▲0.013 ▲0.055
Long Term Debt To Capital Ratio 0.661 ▼-0.044 ▼-0.007
Financial Leverage Ratio 13.061 ▲0.773 ▲1.189
Working Capital Turnover Ratio -1.021 ▼-0.380 ▼-0.365
Operating Cash Flow Ratio 0.597 ▲0.694 ▲0.508
Operating Cash Flow Sales Ratio 0.844 ▲1.210 ▲0.837
Free Cash Flow Operating Cash Flow Ratio 0.981 ▼-0.044 ▼-10.283
Debt Service Coverage Ratio 0.049 ▼-0.008 ▼-0.103
Interest Coverage Ratio 0.108 ▼-0.009 ▼-0.107
Short Term Operating Cash Flow Coverage Ratio 0.597 ▲0.920 ▲0.498
Operating Cash Flow Coverage Ratio 0.331 ▲0.464 ▲0.360
Capital Expenditure Coverage Ratio 52.377 ▲92.152 ▲53.429
Dividend Paid And Capex Coverage Ratio 15.605 ▲25.939 ▲15.268
Dividend Payout Ratio 0.500 ▲0.121 ▼-0.044
Enterprise Value Multiple 29.772 ▲2.405 ▲5.204

Key metrics

MetricTrend20252024202320222021
Market cap$192.94B$125.66B$176.62B$162.18B$203.31B
Enterprise value$836.24B$646.84B$636.66B$591.12B$313.83B
EV / Sales2.68x2.59x2.50x2.47x1.99x
EV / Op. cash flow3.18x-7.08x-3584.26x11.88x-3.08x
EV / Free cash flow3.24x-6.91x-68.32x14.65x-2.95x
EV / EBITDA29.77x27.37x38.06x19.52x8.12x
Net debt / EBITDA22.90x22.05x27.50x14.16x2.86x
Current ratio0.58x0.55x0.61x0.48x0.48x
Income quality11.11x-5.29x-0.02x2.02x-3.10x
Graham number$29$24$22$26$24
Graham net-net-$179-$132-$114-$117-$95
Tax burden112.6%102.1%139.6%86.2%70.5%
Interest burden100.0%100.0%100.0%100.0%100.0%
Working capital-$185.59B-$425.04B-$353.40B-$423.89B-$449.26B
Invested capital-$150.44B-$391.07B-$320.18B-$393.12B-$420.83B
Return on assets1.0%0.8%0.7%1.2%1.4%
Operating ROA1.0%0.8%0.5%1.4%2.0%
Return on tangible assets1.0%0.8%0.7%1.2%1.4%
Return on equity13.3%10.2%8.6%13.3%15.5%
Return on invested capital0.9%1.2%0.8%1.8%2.9%
Return on capital employed1.1%1.5%1.0%2.5%4.1%
Earnings yield12.3%13.7%8.1%13.1%11.4%
Free cash flow yield133.7%-74.5%-5.3%24.9%-52.3%
Capex / Op. cash flow1.9%-2.5%-5145.9%18.9%-4.3%
Capex / Depreciation0.0%34.1%140.2%166.2%76.4%
Capex / Sales1.6%0.9%3.6%3.9%2.8%
SG&A / Sales14.4%17.3%16.0%16.7%24.8%
R&D / Sales0.0%0.0%0.0%0.0%0.0%
Stock comp / Sales0.0%0.0%0.0%0.0%0.0%
Intangibles / Total assets1.1%1.1%1.1%1.0%0.9%
Days sales outstanding0d49d37d39d52d
Days payables outstanding0d0d0d0d0d
Operating cycle0d49d37d39d52d
Cash conversion cycle0d49d37d39d52d

Change by theme

Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.

Change over 1 year

Valuation
Market cap ▲+53.5%EV / Sales ▲+3.5%EV / EBITDA ▲+8.8%EV / Op. cash flow ▲+10.262Earnings yield ▼-0.015Graham number ▲+5.051
Profitability
Return on equity ▲+0.030Return on assets ▲+0.002Return on invested capital ▼-0.003Return on capital employed ▼-0.004Operating ROA ▲+0.001Income quality ▲+16.405Tax burden ▲+0.105
Efficiency
Days sales outstanding ▼-48.518Days payables outstanding n/aOperating cycle ▼-48.518Cash conversion cycle ▼-48.518Capex / Sales ▲+0.007R&D / Sales n/a
Balance-sheet strength
Current ratio ▲+0.032Net debt / EBITDA ▲+0.852Working capital ▲+239454107000.000Invested capital ▲+240629605000.000Intangibles / Total assets -0.000

Change over 5 years

Valuation
Market cap ▼-5.1%EV / Sales ▲+34.7%EV / EBITDA ▲+266.4%EV / Op. cash flow ▲+6.256Earnings yield ▲+0.009Graham number ▲+5.335
Profitability
Return on equity ▼-0.022Return on assets ▼-0.004Return on invested capital ▼-0.020Return on capital employed ▼-0.030Operating ROA ▼-0.010Income quality ▲+14.217Tax burden ▲+0.421
Efficiency
Days sales outstanding ▼-52.030Days payables outstanding n/aOperating cycle ▼-52.030Cash conversion cycle ▼-52.030Capex / Sales ▼-0.012R&D / Sales n/a
Balance-sheet strength
Current ratio ▲+0.097Net debt / EBITDA ▲+20.042Working capital ▲+263670231000.000Invested capital ▲+270391269000.000Intangibles / Total assets ▲+0.002

Employee count

Peer market caps

Congressional trades

STOCK Act disclosures (90-day window)

Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.

No STOCK Act disclosures for this company in this window.

Recent news